Product Information

DORZOLAMIDE-TIMOLOL EYE DROPS is a generic product labeled by Somerset Therapeutics, LLC, priced at $0.9242 per ML under NDC 70069005101. Its NADAC has been published 363 times since Dec 11, 2019.

FDA first approved this application on Jun 25, 2019. Its Orange Book therapeutic-equivalence code is AT1.

DORZOLAMIDE-TIMOLOL EYE DROPS

DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE
$0.9242per ML

Strength

20; 5 mg/mL; mg/mL

NDC

70069005101

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207523

FDA Approved

6/25/2019

TE Code

AT1

On Market Since

6/25/2019

Pharmacological Classes

Adrenergic beta-Antagonists
Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors
beta-Adrenergic Blocker

Price Statistics

The NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has been published 363 times since Dec 11, 2019, and over the history we have for it it has declined 44.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9242 per ML
All-time high$1.8342 (Jul 15, 2020)
All-time low$0.8853 (Jul 22, 2026)
52-week high$0.9641
52-week low$0.8853
Median price$1.1485
Average price$1.2422
Largest weekly change+16.8% (Jun 19, 2024)
Weeks tracked363
Tracking sinceDec 11, 2019

Price History

1W

+0.9%

1M

+3.5%

3M

+3.7%

6M

-0.6%

1Y

-4.1%

3Y

-16.0%

5Y

-36.4%

All

-44.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DORZOLAMIDE-TIMOLOL EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE-TIMOLOL EYE DROPS, manufactured by Somerset Therapeutics, LLC, is $0.9242 per ML (NDC 70069005101), effective Nov 18, 2026.

How has the price of DORZOLAMIDE-TIMOLOL EYE DROPS changed over time?

Over the history we have for it, the NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has declined 44.6%. It has been tracked across 363 weekly CMS publications since Dec 11, 2019.

What are the highest and lowest recorded NADAC prices for DORZOLAMIDE-TIMOLOL EYE DROPS?

Since Dec 11, 2019, the NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has ranged from a low of $0.8853 (Jul 22, 2026) to a high of $1.8342 (Jul 15, 2020), with a median of $1.1485 per ML.

Are there cheaper alternatives to DORZOLAMIDE-TIMOLOL EYE DROPS?

No other NADAC-published product currently shares the active ingredient and strength of DORZOLAMIDE-TIMOLOL EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DORZOLAMIDE-TIMOLOL EYE DROPS?

DORZOLAMIDE-TIMOLOL EYE DROPS (NDC 70069005101) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.